Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Moses S. Raj"'
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-5 (2023)
Abstract Background Since the inception of targeted therapies in treating lung cancer, providers have had to be aware of a new host of side effects when selecting management options for patients. Although targeted therapies are creating increased hop
Externí odkaz:
https://doaj.org/article/82b88e43addb44659c2e777713f90591
Publikováno v:
Cancers, Vol 15, Iss 18, p 4426 (2023)
Immunotherapy has shown promise as a treatment option for gastroesophageal cancer, but its effectiveness is limited in many patients due to the immunosuppressive tumor microenvironment (TME) commonly found in gastrointestinal tumors. This paper explo
Externí odkaz:
https://doaj.org/article/260cdbf3f5a0402d9887641ee4948df5
Publikováno v:
Cureus.
Publikováno v:
Cureus
Chronic lymphocytic leukemia is the most common blood cancer in adults. A major cause of morbidity and mortality associated with this cancer stems from opportunistic infections. Similar to many cancers, the inherent effects of battling a raging disea
Autor:
Moses S. Raj, Gene Grant Finley, James McCormick, Stephen Abel, Stanislav Nosik, Rodney E. Wegner, Dulabh Monga, Alexander V. Kirichenko
Publikováno v:
Annals of Surgical Oncology. 27:825-832
Adjuvant radiation is generally not recommended for colon cancer but may be considered in certain clinical scenarios [advanced local disease (pT4) and/or positive margins]. Guidelines in this area are lacking; thus we analyzed the National Cancer Dat
Autor:
Paul Renz, Rodney E. Wegner, Moses S. Raj, Robin Raquel Rodriguez, Stephen Abel, Jyothika Mamadgi
Publikováno v:
Journal of gastrointestinal cancer. 53(3)
Background Each year, approximately 8000 cases of cholangiocarcinoma are recorded in the USA. Surgical resection is considered to be the only curative option. Despite surgery as a curative approach, many patients will require adjuvant therapies in th
Autor:
Ashish Sethi, Stephen Abel, Rodney E. Wegner, Paul Renz, Alexander V. Kirichenko, Patrick Wagner, James McCormik, Gene Grant Finley, Moses S. Raj
Publikováno v:
Journal of Clinical Oncology. 40:e15595-e15595
e15595 Background: Total Neoadjuvant therapy (TNT) has gained acceptance in the treatment of locally advanced rectal cancer, although the optimal sequencing of therapy chemoradiation (CRT) followed by consolidation chemotherapy (cChT) or induction ch
Autor:
Ronan Joseph Kelly, Vincent K. Lam, Scott Paulson, Natalie Settele, Oghenevovwero Sido, Valsamo Anagnostou, Moses S. Raj, Ali Hussainy Zaidi
Publikováno v:
Journal of Clinical Oncology. 40:TPS4169-TPS4169
TPS4169 Background: Cyclin dependent kinases (CDKs) are serine/threonine kinases that are responsible for phosphorylating the intracellular proteins that coordinate cell-cycle progression. The Cancer Genome Atlas (TCGA) molecular analysis of esophage
Autor:
Thomas J. George, Greg Yothers, Anuradha Krishnamurthy, Saima Sharif, Caio Max Sao Pedro Rocha Lima, Howard S. Hochster, Jesus C. Fabregas, Alok A. Khorana, Martin Gutierrez, Moses S. Raj, Ana Acuna Villaorduna, Carmen Joseph Allegra, Samuel A. Jacobs, Alexey Aleshin, Stacie Ittershagen, Shannon Leigh Huggins-Puhalla, Norman Wolmark
Publikováno v:
Journal of Clinical Oncology. 40:TPS3642-TPS3642
TPS3642 Background: Detection of circulating tumor DNA (ctDNA) in patients (pts) following surgery is indicative of presence of minimal/molecular residual disease (MRD) and confers a near-certain risk of disease recurrence. Therapeutic strategies to
Autor:
Ashish Sethi, Moses S. Raj
Publikováno v:
Cureus
Pembrolizumab is an immune checkpoint inhibitor approved for use in many cancer types such as non-small cell lung cancer (NSCLC), metastatic melanoma, head and neck cancers, hepatocellular carcinoma, and renal cell carcinoma. There are many reported